Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,185,008 papers from all fields of science
Search
Sign In
Create Free Account
aminotadalafil
Known as:
(6R,12aR)-2-amino-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
, Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 2-amino-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-, (6R,12aR)-
, RR-ATDF
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzodioxoles
Carbolines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Armenia-ATDF (entity)-Audit Report 2017
L. Grigoryan
2018
Corpus ID: 169377829
2013
2013
Simultaneous identification of hydroxythiohomosildenafil, aminotadalafil, thiosildenafil, dimethylsildenafil, and thiodimethylsildenafil in dietary supplements using high-performance liquid…
Takaomi Tagami
,
Akihiro Takeda
,
+4 authors
Y. Sawabe
Shokuhin eiseigaku zasshi. Journal of the Food…
2013
Corpus ID: 41869921
We developed a method for the separation and identification of illegal adulterants (hydroxythiohomosildenafil, aminotadalafil…
Expand
2011
2011
Studies on the system methods for determination of adulteration anti-fatigue health food
L. Yi
2011
Corpus ID: 75755002
Objective:To establish a rapid detection system of adulteration in the anti-fatigue health food.Methods:Chemical reactions…
Expand
2008
2008
Identi fi cation of Aminotadala fi l and its Stereoisomers Contained in Health Foods Using Chiral Liquid Chromatography-Mass Spectrometry
Hiroyuki Kurita
,
K. Mizuno
,
+7 authors
Masatoshi Yamamoto
2008
Corpus ID: 55302935
Using chiral liquid chromatography-mass spectrometry (LC/MS), a simple and rapid identification test was developed for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE